Cagrilintide/Ipamorelin

Weight Loss

1Vendor

Niche stack aimed at losing fat without giving up recovery or lean-mass support. Real-world use is mostly merchandising logic—appetite control from cagri plus GH support from ipamorelin.

View Vendors

Studies
Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants.	PubMed
Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial.	PubMed
Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.	PubMed

Cagrilintide/Ipamorelin Vendors
Peptira 0.0	Profile

Cagrilintide/Ipamorelin Vendors